0
0
10/27/22 at 6:10am
Organization
Cancertherapyadvisor.com
Author
Erin Clancy
33 words
0
Comments
Response-adapted ultra-low-dose radiation therapy demonstrated efficacy and negligible toxicity in orbital indolent B-cell lymphoma.
You are the first to view
https://www.cancertherapyadvisor.com/home/news/conference-coverage/astro-2022/orbital-indolent-b-cell-lymphoma-ultra-low-dose-radiation-therapy-effective/
Create an account
or login to join the discussion